Status:

COMPLETED

Safety and Effectiveness of Collagen-phosphorylcholine Bioengineered Cornea in Patients Requiring Lamellar Keratoplasty

Lead Sponsor:

The Filatov Institute of Eye Diseases and Tissue Therapy

Collaborating Sponsors:

Linkoeping University

Conditions:

Corneal Ulcer

Leukoma

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

In this study the safety and effectiveness of biosynthetic cornea, comprising interpenetrating networks of recombinant human collagen and phosphorylcholine, will be tested in patients with severe corn...

Detailed Description

Collagen-phosphorylcholine corneal substitute will be implanted in patient's corneas with severe pathology (corneal ulcer, corneal leukoma after burn, trauma or infection) using anterior lamellar kera...

Eligibility Criteria

Inclusion

  • Subjects must sign and be given a copy of the written Informed Consent form.
  • Subjects with best corrected distance visual acuity 20/200 or worse as a result of corneal ulcer or corneal scar due to burn, injury or infection in the operative eye.
  • Subjects must be willing and able to return for scheduled follow-up examinations for 12 months after surgery.

Exclusion

  • Subjects with severe or life-threatening systemic disease.
  • Subjects with uncontrolled hypertension.
  • Subjects with uncontrolled diabetes or insulin-dependent diabetes.
  • Subjects with glaucoma in either eye.
  • Subjects with marked microphthalmos or aniridia in either eye.
  • Subjects with any other serious ocular pathology, serious ocular complications at the time of corneal transplant underlying serious medical conditions, based on the investigator's medical judgment.
  • Subjects which are or lactating or who plan to become pregnant over the course of the clinical investigation.

Key Trial Info

Start Date :

March 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2017

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT02277054

Start Date

March 1 2013

End Date

January 1 2017

Last Update

October 26 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Filatov Institute of Eye Diseases and Tissue Therapy

Odesa, Ukraine, 65061